Brief: Expres2ion Q4 Loss After Financial Items Widens To SEK 18.8 Mln
Feb 25 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* EXPRES2ION ANNOUNCES 2020 FOURTH QUARTER AND FULL-YEAR
RESULTS
* Q4 NET SALES AMOUNTED TO 5,277 (3,611) KSEK.
* Q4 RESULT AFTER FINANCIAL ITEMS AMOUNTED TO -18,772
(-7,502)
KSEK.
Source text for Eikon: ID:nWkr8y3zkf
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations